ACE2 and COVID-19: Because of the discussed uncertainties and the lack of robust evidence, we strongly opine that the suggested mutant ACE2-mediated protection offered by antecedent malaria exposure against SARS-CoV-2 infection and COVID-19 pathogenesis needs to be scrutinized.